| __timestamp | Gilead Sciences, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3788000000 | 241751000 |
| Thursday, January 1, 2015 | 4006000000 | 322292000 |
| Friday, January 1, 2016 | 4261000000 | 344320000 |
| Sunday, January 1, 2017 | 4371000000 | 374644000 |
| Monday, January 1, 2018 | 4853000000 | 1820000 |
| Tuesday, January 1, 2019 | 4675000000 | 4000000 |
| Wednesday, January 1, 2020 | 4572000000 | 12000000 |
| Friday, January 1, 2021 | 6601000000 | 11000000 |
| Saturday, January 1, 2022 | 5657000000 | 14000000 |
| Sunday, January 1, 2023 | 6498000000 | 9133000 |
| Monday, January 1, 2024 | 28675800000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, understanding the cost dynamics of leading companies is crucial. Gilead Sciences, Inc. and Ionis Pharmaceuticals, Inc. have been pivotal players in this field. From 2014 to 2023, Gilead's cost of revenue has shown a robust upward trend, peaking in 2021 with a 74% increase from 2014. In contrast, Ionis Pharmaceuticals experienced a more volatile trajectory, with a significant drop in 2018, where costs plummeted by over 99% compared to the previous year. This fluctuation highlights the differing operational strategies and market challenges faced by these companies. Gilead's consistent growth in cost of revenue suggests a stable expansion strategy, while Ionis's variability may reflect its adaptive approach to market demands. As the biotech industry continues to grow, these insights provide a window into the financial health and strategic directions of these key players.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Gilead Sciences, Inc.
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs HUTCHMED (China) Limited
Cost of Revenue Comparison: Gilead Sciences, Inc. vs Mesoblast Limited
GSK plc vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Viatris Inc. vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Ionis Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Ionis Pharmaceuticals, Inc. and HUTCHMED (China) Limited
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Cost Insights: Breaking Down Ionis Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd.'s Expenses
Ionis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored